We propose to establish the UNC Interdisciplinary Program in Breast Cancer Research to serve as a national Specialized Program of Research Excellence (SPORE) in Breast Cancer for the National Cancer Institute. The UNC SPORE will have a unique set of goals, objectives, and programs that capitalize on and extend in novel ways the existing excellence in multidisciplinary breast cancer research at UNC and the UNC Lineberger Comprehensive Cancer Center. The goal of the UNC SPORE is to reduce breast cancer mortality and incidence in North Carolina through an interdisciplinary program of research and intervention that: 1. Integrates efforts in cancer prevention and control, molecular epidemiology, clinical research, and laboratory clinical research; and 2. Targets behavioral and biological issues relevant to Black women. The six primary objectives of the UNC SPORE are: 1. To identify the determinants of the Black/White gap in breast cancer mortality in North Carolina, and then to use novel community and provider interventions to close that gap; 2. To initiate a long-term, population-based study of breast cancer in a defined North Carolina population containing 1.6 million women, 27% of whom are minorities; 3. To combine molecular biology and epidemiology in the investigation of the environmental determinants of and genetic predispositions to breast cancer in blacks and whites in the defined population; 4. To improve the treatment, quality-of-life, and prognosis of late-stage breast cancer, a common presentation among Black women in North Carolina; 5. To develop new clinical markers for neoplastic proliferation of breast cancer cells; and 6. To complement the NCI and other SPOREs in the national effort to reduce breast cancer mortality and incidence with a focus on minority issues, development of a defined population, and research programs in cancer prevention and control, molecular epidemiology, clinical research, and the isolation and molecular analysis of novel regulatory genes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA058223-01
Application #
3105281
Study Section
Special Emphasis Panel (SRC (50))
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lei, Jonathan T; Shao, Jieya; Zhang, Jin et al. (2018) Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Cell Rep 24:1434-1444.e7
Troester, Melissa A; Sun, Xuezheng; Allott, Emma H et al. (2018) Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst 110:
Williams, Michelle M; Lee, Linus; Werfel, Thomas et al. (2018) Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell Death Dis 9:21
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Matsunuma, Ryoichi; Chan, Doug W; Kim, Beom-Jun et al. (2018) DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer. Proc Natl Acad Sci U S A 115:E11978-E11987
Panda, Anshuman; de Cubas, Aguirre A; Stein, Mark et al. (2018) Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. JCI Insight 3:
Sharma, Priyanka; López-Tarruella, Sara; García-Saenz, José Angel et al. (2018) Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel. Clin Cancer Res 24:5820-5829
Siegel, Marni B; He, Xiaping; Hoadley, Katherine A et al. (2018) Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J Clin Invest 128:1371-1383
Kumar, Sunil; Lindsay, Daniel; Chen, Q Brent et al. (2018) Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ. NPJ Breast Cancer 4:39
Smith, Christof C; Beckermann, Kathryn E; Bortone, Dante S et al. (2018) Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. J Clin Invest 128:4804-4820

Showing the most recent 10 out of 598 publications